News

May 20, 2019May 20, 2019

Gocovri Leads to Steady ‘On’ States in Parkinson’s Patients, Phase 3 Pooled Data Suggest

News

Gocovri (amantadine) can effectively reduce the number and duration of “off” periods and dyskinesia (uncontrolled movement) episodes in Parkinson’s patients under long-term levodopa treatment, leading to a good steady ... Read more

May 20, 2019May 20, 2019

Aptinyx to Launch Phase 2 Study of NYX-458 to Treat Cognitive Impairment

News

Positive preclinical and Phase 1 clinical data support further assessmentof Aptinyx‘s investigational compound NYX-458 for the treatment of cognitive impairment associated with Parkinson’s disease in new Phase 2 studies. Aptinyx ... Read more

May 17, 2019May 17, 2019

‘ParkinSong’ and Other Song Therapy Programs May Help Preserve Speech, Study Says

News

Intensive singing interventions have the potential to increase vocal loudness, respiratory muscle strength, and voice-related quality of life in people with Parkinson’s disease, a study suggests. The study, “ParkinSong: ... Read more

May 17, 2019May 17, 2019

Parkinson’s Medications Relieve Central Pain Better than Other Types of Pain, Study Finds

News

Treatment with standard Parkinson’s therapies, such as levodopa or dopamine agonists, can provide effective relief of central parkinsonian pain, but they may fail to manage motor symptoms in these ... Read more

May 16, 2019May 16, 2019

Abbott Partners with NIH on BRAIN Initiative to Use Neuromodulation Technologies

News

Abbott is partnering with the National Institutes of Health (NIH) to explore the use of its neuromodulation technologies for treating chronic pain and progressive movement disorders, including Parkinson’s disease. ... Read more

May 16, 2019May 16, 2019

PatientPoint Launches Digital Support Network for Neurologists, Patients, and Caregivers

News

PatientPoint, in collaboration with five U.S. patient advocacy organizations, has introduced a technology-driven point-of-care network for neurologists, neurology patients, and caregivers. With a focus on neurological conditions such as ... Read more

May 15, 2019May 15, 2019

Lysosome-targeting Therapies Can Potentially Reverse LRRK2 Effects in Parkinson’s, Study Suggests

News

Mutations in the LRRK2 gene, which have been linked to familial Parkinson’s disease, impair the activity of the waste clearance system inside nervous brain cells, contributing to their progressive ... Read more

May 15, 2019May 15, 2019

Early Involvement of Caudate Brain Region Linked to Worse Prognosis in Parkinson’s Patients, Study Finds

News

Almost half of people in the early stages of Parkinson’s disease already have signs of neurodegeneration in a brain region called the caudate, which was previously thought to affect ... Read more

May 14, 2019May 14, 2019

Centogene Launches 2-Year Global ROPAD Study to Assess the Genetics of Parkinson’s Disease

News

A two-year, global, observational study that will assess the contribution of genetic factors in the development of Parkinson’s disease has been launched by Centogene, in collaboration with the University ... Read more

May 14, 2019May 14, 2019

Appendectomy Is Linked to Higher Risk of Parkinson’s, Study Suggests

News

People who have appendectomies have more than three times the risk of developing Parkinson’s disease, according to the findings of a U.S. large-scale study. The study, “Parkinson’s Disease Is ... Read more

Pin It on Pinterest